Atlas Trials

REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL)

Clinical trial NCT01483560 · COMPLETED

Trial details

NCT number
NCT01483560
Sponsor
University of Glasgow
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1
Start date
2011-12-01
Primary completion
2017-03-19
Enrollment
493

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.